Search Results 661-670 of 18765 for Insulin

  1. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Stable regimen of oral anti-hyperglycemic therapy without insulin usage for at least 3 weeks prior to first study treatment ... Insulin-dependent diabetes ...

  2. Diabetes - Doctors and departments - Mayo Clinic

    Diabetes treatment: Can cinnamon lower blood sugar? Diabetes treatment: Using insulin to manage blood sugar · Glycemic index: A helpful tool for diabetes?

  3. Effects of Chardonnay Seed Flour on Vascular Health - Mayo Clinic

    We will examine the effect of CSF on parameters such as endothelial function (via EndoPAT testing), plasma lipid levels, glucose tolerance, insulin ...

  4. Publications - Andrea R. Huebner, Ph.D., L.P. - Mayo Clinic

    Brain functions and cognition on transient insulin deprivation in type 1 diabetes. JCI Insight. 2021 Mar 08; 6(5). View PubMed; Mehta SQ, Behl S, Day PL ...

  5. A Study to Evaluate Hypoxia and Inflammatory Injury in Human Renovascular Hypertension - Mayo Clinic

    Diabetes requiring insulin or oral hypoglycemic medications. Known allergy to furosemide or iodinated intravenous contrast. Pregnancy. Recent Cardiovascular ...

  6. A Study To Test The Effect Of BI 456906 On Cardiovascular Safety In People With Overweight Or Obesity (SYNCHRONIZE™ - CVOT) - Mayo Clinic

    Less than 3 months between the last dose of GLP-1R agonists and GLP-1R agonist/insulin/glucose-dependent insulinotropic polypeptide (GIP) combinations and ...

  7. Beta blockers: How do they affect exercise? - Mayo Clinic

    Will I need a kidney transplant? IgA nephropathy (Berger disease) · Insulin and weight gain: Keep the pounds off · Intracranial hematoma · Isolated systolic ...

  8. A Study of the Effects of a Nocturnal Rise in Cortisol on Glucose Production in Type 2 Diabetes - Mayo Clinic

    ... insulin, with HbA1c <10% ... Subjects on long acting insulin will stop their insulin 24 hours before study admit day and continue short acting insulin as needed.

  9. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Effectiveness of Nimacimab in Patients With Diabetic Gastroparesis - Mayo Clinic

    Participants with controlled diabetes and stable blood glucose levels are allowed (insulin is allowed). HbA1c > 9.9% at screening are excluded. Participants ...

  10. Hyoscyamine, methenamine, methylene blue, phenyl salicylate, and sodium phosphate (oral route) - Side effects & dosage - Mayo Clinic

    Insulin; Insulin Aspart, Recombinant; Insulin Bovine; Insulin Degludec; Insulin Detemir; Insulin Glargine, Recombinant; Insulin Glulisine; Insulin Lispro, ...